Elevated Brain Natriuretic Peptide (BNP) is an Early Marker for Patients at Risk for Complications after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS + HIPEC)
Journal of surgical oncology(2017)
摘要
BackgroundElevated BNP is associated with adverse cardiac outcomes after noncardiac surgery. We assessed BNP values as markers of perioperative fluid status and their correlation with major/cardiopulmonary (CP) complications following CRS + HIPEC.MethodsFluid balance, BNP levels, and morbidity data were collected for all patients undergoing CRS + HIPEC between 6/2014 and 2/2016.ResultsOne hundred and twenty‐nine patients underwent CRS + HIPEC for appendiceal adenocarcinoma (n = 99), mesothelioma (n = 16), and colon cancer (n = 14). Less than 10% had CP comorbidities. The median PCI was 14 (range 4‐39); 89% underwent CC0/1 resection (n = 115). Median blood loss (EBL) was 497 mL (50‐2700). Major complications (Clavien III‐V) occurred in 16 (12%), CP in 17 (13%), and major/CP in 24 (18%). Thirty‐day mortality occurred in 2 (1.5%). Elevated BNP on POD1 correlated with increased risk of major/CP complications (OR 2.2, P = 0.052). This was most pronounced in the 25 patients receiving cisplatin: for each 100 unit increase in POD1 BNP the OR for major/CP complication was 7.4 versus 1.2 for the remaining patients, P = 0.083. Multivariate analysis identified increased EBL (OR 4.1 P = 0.011) and a trend toward increased BNP on POD1 (OR for each 100 unit increase 2.0, P = 0.10) as risk factors for major/CP complications.ConclusionsPostoperative BNP measurement after CRS + HIPEC may guide postoperative fluid resuscitation and facilitate identification of patients at risk for major and/or cardiopulmonary complications.
更多查看译文
关键词
BNP,brain natriuretic peptide,cytoreductive surgery,HIPEC,postoperative morbidity
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要